An exoskeleton let a paralyzed man walk, then its maker refused repairs

Right to Repair & Access to Parts

• Many see the case as a textbook argument for right-to-repair: users should have access to parts, documentation, and the ability to self-repair or use third parties.
• Others argue that in this case the user technically had the “right” to repair; the bottleneck was getting a discontinued, niche part manufactured.
• Debate over whether right-to-repair is a “negative right” (no blocking independent repair) or should become a “positive right” (obligation to provide parts/support for some period).

Proprietary vs. Standard Components

• Strong criticism of using proprietary or non-standard connectors when generic parts would suffice and stay sourceable long term.
• Counterpoint: proprietary components are ubiquitous (e.g., smartphones) and not inherently a right‑to‑repair violation unless combined with legal/technical barriers (DRM, licensing, pairing checks).
• Some argue that publishing specs/BOMs at end-of-life would let repair shops “bodge together” safe replacements, even for low-volume devices.

Regulation and FDA Constraints

• Disagreement over whether FDA rules truly barred the manufacturer from servicing the older device or if “regulations” were used as a convenient excuse.
• References to device “intended working life” (5 years) and how changes to control mechanisms may count as remanufacturing requiring new clearance.
• Some argue regulators should require backup/manual controls and separate non-medical peripherals (like remotes) from life‑span limits.
• Unclear from the thread exactly which FDA rule applied and whether the company could have lawfully serviced the device.

Economics, Niche Devices, and Support Lifetimes

• Concerns that mandating decades of parts support for ultra‑niche, $100k exoskeletons could kill innovation or be economically infeasible.
• Others note that long-term support is routine in sectors like cars and aircraft, and medical devices with life‑altering impact should have similar expectations.
• Suggestions that insurers/governments could require or fund long-term parts availability, or that such devices might better be leased with ongoing maintenance.

Healthcare Systems & Access

• U.S. Medicare coverage is partial and excludes some injury types; commenters see this as emblematic of U.S. healthcare friction.
• Some claim exoskeletons and advanced care are more straightforwardly covered in certain socialized systems; others say “fights with administration” exist there too.

Journalism & Missing Context

• Multiple commenters criticize the article for not deeply examining the FDA/regulatory angle, focusing instead on corporate blame.
• Some attribute this to underfunded, deadline‑driven journalism that can’t support detailed technical investigation.

Broader Policy Proposals

• Ideas floated include: mandatory post‑EOL open-sourcing of schematics/firmware, source‑code escrow tied to regulatory approval, or laws prioritizing consumers in bankruptcy so essential IP can be opened.
• Others warn these measures might clash with IP rights, creditor interests, and existing business/legal structures.